Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease

Summary

The purpose of this trial is to evaluate whether, in Intravenous Immunoglobulin-naïve or refractory patients diagnosed with active Kawasaki disease, administration of canakinumab controls fever and acute phase reactants.

Timeline

Start

2016-11-15

Primary completion

2017-11-30

Completion

2017-11-30

Drugs

Indications